BPI22-024: Assessing the Adherence to Standard of Care With Durvalumab and Overcoming Barriers in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Study
Journal of the National Comprehensive Cancer Network（2022）
Key words
durvalumab,lung cancer,adherence,non-small
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined